TRAF4 can promote both SMAD and non-SMAD signaling downstream of TβRI, during breast cancer progression, and was found to play an important role in mediating TGFβ-induced EMT and metastasis in breast cancer [134]. Here, TGFBR1 is linked to breast cancer.